RECRUITING

Reward Processing and Exposure Therapy for Social Anxiety Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are conducting a clinical trial of therapy for public speaking anxiety. There are many eligibility criteria, but the main ones are that participants need to be socially anxious and have public speaking anxiety. In this clinical trial, all participants will do exposure therapy. Before doing exposure therapy in the study, though, participants will be randomized to do one of two treatments: i) a positive mood treatment, which is designed to increase how positive people feel, and ii) a relaxation treatment, which is designed to help people feel more relaxed. The investigators are doing this study to see whether doing the positive mood treatment or relaxation treatment first will affect how well exposure therapy works.

Official Title

Reward Processing and Exposure Therapy

Quick Facts

Study Start:2024-09-26
Study Completion:2029-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06776991

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Tomislav D Zbozinek, PhD
CONTACT
6027502348
tzbozinek@ucla.edu

Principal Investigator

Tomislav D Zbozinek, PhD
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Michelle G Craske, PhD
STUDY_CHAIR
University of California, Los Angeles

Study Locations (Sites)

University of California, Los Angeles
Los Angeles, California, 90024
United States
University of California, Los Angeles
Los Angeles, California, 90024
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

  • Tomislav D Zbozinek, PhD, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles
  • Michelle G Craske, PhD, STUDY_CHAIR, University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-26
Study Completion Date2029-04-30

Study Record Updates

Study Start Date2024-09-26
Study Completion Date2029-04-30

Terms related to this study

Keywords Provided by Researchers

  • Exposure Therapy
  • Anxiety
  • Social Anxiety
  • Public Speaking Anxiety
  • Anhedonia
  • Reward Processing
  • Inhibitory Retrieval
  • Positive Affect Treatment
  • Relaxation Treatment

Additional Relevant MeSH Terms

  • Social Anxiety Disorder (Social Phobia)
  • Public Speaking Anxiety
  • Anhedonia
  • ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
  • Phobic Disorders